title: Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
abstract: The aim of the study was to develop a drug-in-adhesive patch system for transdermal delivery of zaltoprofen (ZAL). The formulation was designed in combination with the ion pair and chemical enhancer strategy. Seven organic amines were chosen as counter ions, and the prepared ion pairs were characterized by Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). The in vivo pharmacokinetic performance of ZAL was studied on rabbits following transdermal and intravenous administration. A deconvolution method was applied to determine the correlation between the in vitro permeation and the in vivo absorption. Acetic acid-induced writhing response was conducted on mice to evaluate the analgesic effect. In vitro permeation results showed that both ion pairs and chemical enhancers were effective in modulating ZAL skin permeation from patches. The enhancement ratio was negatively correlated to the polar surface area (PSA) of counter ions, and was positively correlated to the octanol-water partition coefficient (log Ko/w) of chemical enhancers, respectively. The optimized formulation contained 10% (w/w) ZAL-triethylamine and 10% (w/w) isopropyl myristate, with DURO-TAK® 87-4098 as the pressure sensitive adhesive matrix. Furthermore, the in vitro permeation data were well correlated with the in vivo absorption data. The analgesic effect of the optimized patch was comparable to the commercial indometacin plasters. In conclusion, it was feasible for transdermal delivery of ZAL by the synergistic action of ion pair and chemical enhancer, and the in vitro permeation data were indicative of the in vivo performance for the developed patches.
authors.affiliation: a Department of Pharmaceutical Sciences , School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , Liaoning , China.
authors.forename: Hongxia
authors.initials: H
authors.lastname: Cui
authors.affiliation: a Department of Pharmaceutical Sciences , School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , Liaoning , China.
authors.forename: Peng
authors.initials: P
authors.lastname: Quan
authors.affiliation: a Department of Pharmaceutical Sciences , School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , Liaoning , China.
authors.forename: Zhuang
authors.initials: Z
authors.lastname: Zhou
authors.affiliation: a Department of Pharmaceutical Sciences , School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , Liaoning , China.
authors.forename: Liang
authors.initials: L
authors.lastname: Fang
mesh_terms: D000269:Adhesives / Q000008:administration & dosage* / Q000737:chemistry*; D000279:Administration, Cutaneous; D000818:Animals; D001578:Benzopyrans / Q000008:administration & dosage* / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning / Q000379:methods; D002626:Chemistry, Pharmaceutical / Q000379:methods; D008297:Male; D051379:Mice; D010539:Permeability; D011422:Propionates / Q000008:administration & dosage* / Q000737:chemistry*; D011817:Rabbits; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption / Q000502:physiology; D057968:Transdermal Patch
chemical_list: D000269:Adhesives; D001578:Benzopyrans; D011422:Propionates; C043940:pyranoprofen
keywords: Ion pair; in vitro/in vivo correlation; pharmacokinetic; transdermal; zaltoprofen